Discontinued — last reported Q4 '25
West Pharmaceutical Services Compensation and benefits decreased by 21.4% to $6.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 407.7%, from $1.30M to $6.60M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase often reflects headcount growth or higher performance-based incentives, while a decrease may indicate efficiency initiatives or workforce reductions.
Includes all salaries, wages, bonuses, stock-based compensation, and employee benefit costs for the workforce. This is t...
Highly comparable across all sectors; usually found under 'Personnel' or 'Staffing' expenses.
compensation_and_benefits| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.30M | $11.30M | $5.50M | $5.50M | $6.00M | $8.50M | $7.50M | $5.90M | $5.00M | $4.30M | $5.10M | $1.30M | $7.40M | $8.40M | $6.60M |
| QoQ Change | — | +9.7% | -51.3% | +0.0% | +9.1% | +41.7% | -11.8% | -21.3% | -15.3% | -14.0% | +18.6% | -74.5% | +469.2% | +13.5% | -21.4% |
| YoY Change | — | — | — | -46.6% | -46.9% | +54.5% | +36.4% | -1.7% | -41.2% | -42.7% | -13.6% | -74.0% | +72.1% | +64.7% | +407.7% |